VRAY
Price:
$0.025
Market Cap:
$0
ViewRay, Inc. designs, manufactures, and markets magnetic resonance imaging (MRI) guided radiation therapy systems to image and treat cancer patients in the United States, France, Taiwan, the United Kingdom, and internationally. The company provides MRIdian, which is an MRI guided radiation therapy system that addresses beam distortion, skin toxicity, and other concerns. The company serves university research and teaching hospitals, community hospitals, private practices, government institutions, and freestanding cancer centers. ViewRay, Inc. markets its MRIdian through a direct sales force and distribution network. The company was founded in 2004 and is headquartered in Oakwood, Ohio.[Read more]
Industry
Medical - Devices
IPO Date
2015-08-10
Stock Exchange
NASDAQ
Ticker
VRAY
According to ViewRay, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.10. This represents a change of -98.23% compared to the average of -5.66 of the last 4 quarters.
The mean historical PE Ratio of ViewRay, Inc. over the last ten years is -4.36. The current -0.10 PE Ratio has changed 129.20% with respect to the historical average. Over the past ten years (40 quarters), VRAY's PE Ratio was at its highest in in the November 2014 quarter at 0. The PE Ratio was at its lowest in in the November 2013 quarter at -11014.25.
Average
-4.36
Median
-4.43
Minimum
-8.54
Maximum
0
Discovering the peaks and valleys of ViewRay, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 202.81%
Maximum Annual PE Ratio = 0
Minimum Annual Increase = -Infinity%
Minimum Annual PE Ratio = -8.54
Year | PE Ratio | Change |
---|---|---|
2022 | -7.53 | -11.86% |
2021 | -8.54 | 59.32% |
2020 | -5.36 | 53.28% |
2019 | -3.50 | -45.74% |
2018 | -6.45 | -14.06% |
2017 | -7.50 | 202.81% |
2016 | -2.48 | 16.23% |
2015 | -2.13 | -Infinity% |
2014 | 0 | -100.00% |
The current PE Ratio of ViewRay, Inc. (VRAY) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-7.14
5-year avg
-6.27
10-year avg
-4.36
ViewRay, Inc.’s PE Ratio is greater than Alphatec Holdings, Inc. (-5.06), less than Acutus Medical, Inc. (-0.02), greater than AxoGen, Inc. (-34.41), greater than Delcath Systems, Inc. (-4.87), greater than NeuroPace, Inc. (-6.95), greater than CVRx, Inc. (-3.35), greater than Orthofix Medical Inc. (-5.12), greater than Artivion, Inc. (-125.20), greater than Heska Corporation (-91.49), greater than Anika Therapeutics, Inc. (-4.91), greater than Sight Sciences, Inc. (-6.06), less than Avanos Medical, Inc. (141.40), greater than Bone Biologics Corporation (-0.27), greater than Heart Test Laboratories, Inc. (-0.29), greater than Tivic Health Systems, Inc. (-0.19), greater than Vivos Therapeutics, Inc. (-0.70), less than Talis Biomedical Corporation (-0.06), greater than Inogen, Inc. (-2.89), greater than Establishment Labs Holdings Inc. (-13.95),
Company | PE Ratio | Market cap |
---|---|---|
-5.06 | $901.05M | |
-0.02 | $952.94K | |
-34.41 | $570.66M | |
-4.87 | $270.76M | |
-6.95 | $210.22M | |
-3.35 | $183.44M | |
-5.12 | $619.96M | |
-125.20 | $1.05B | |
-91.49 | $1.31B | |
-4.91 | $363.41M | |
-6.06 | $319.45M | |
141.40 | $1.09B | |
-0.27 | $2.14M | |
-0.29 | $2.52M | |
-0.19 | $2.03M | |
-0.70 | $8.91M | |
-0.06 | $2.83M | |
-2.89 | $268.02M | |
-13.95 | $1.16B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like ViewRay, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like ViewRay, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is ViewRay, Inc.'s PE Ratio?
How is the PE Ratio calculated for ViewRay, Inc. (VRAY)?
What is the highest PE Ratio for ViewRay, Inc. (VRAY)?
What is the 3-year average PE Ratio for ViewRay, Inc. (VRAY)?
What is the 5-year average PE Ratio for ViewRay, Inc. (VRAY)?
How does the current PE Ratio for ViewRay, Inc. (VRAY) compare to its historical average?